var anylinkmenu1={divclass:'anylinkmenu', inlinestyle:'', linktarget:''}
anylinkmenu1.items=[
	["Board of Directors", "http://www.xenoport.com/aboutus/bod.htm"],
	["Management", "http://www.xenoport.com/aboutus/management.htm"],
	["Business Development", "http://www.xenoport.com/aboutus/busdev.htm"]
]
var anylinkmenu3={divclass:'anylinkmenu', inlinestyle:'', linktarget:''} 
anylinkmenu3.items=[
	["XenoPort Pipeline", "http://www.xenoport.com/research_development/pipeline.htm"],
	["Gabapentin Enacarbil", "http://www.xenoport.com/research_development/Gabapentin_enacarbil.htm"],
	["Arbaclofen Placarbil", "http://www.xenoport.com/research_development/ap.htm"],
	["XP21279", "http://www.xenoport.com/research_development/xp21279.htm"],
	["Preclinical Candidates", "http://www.xenoport.com/research_development/preclinical_candidates.htm"],
	["Our Technology", "http://www.xenoport.com/research_development/our_technology.htm"]
]
var anylinkmenu4={divclass:'anylinkmenu', inlinestyle:'', linktarget:''} 
anylinkmenu4.items=[
	["Calendar of Events", "http://phx.corporate-ir.net/phoenix.zhtml?c=187883&p=irol-calendar"],
	["Press Releases", "http://phx.corporate-ir.net/phoenix.zhtml?c=187883&p=irol-news&nyo=0"],
	["SEC Filings", "http://phx.corporate-ir.net/phoenix.zhtml?c=187883&p=irol-sec"],
	["Stock Information", "http://phx.corporate-ir.net/phoenix.zhtml?c=187883&p=irol-stockQuote"],
	["Corporate Governance", "http://phx.corporate-ir.net/phoenix.zhtml?c=187883&p=irol-govHighlights"],
	["Management", "http://phx.corporate-ir.net/phoenix.zhtml?c=187883&p=irol-govManage"],
	["Analysts", "http://phx.corporate-ir.net/phoenix.zhtml?c=187883&p=irol-analysts"],
	["Investor FAQ", "http://phx.corporate-ir.net/phoenix.zhtml?c=187883&p=irol-faq"],
	["Online Investor Kit", "http://phx.corporate-ir.net/phoenix.zhtml?c=187883&p=irol-investorKit"],
	["Ownership Summary", "http://phx.corporate-ir.net/phoenix.zhtml?c=187883&p=irol-ownershipsummary"],
	["Annual Report", "http://phx.corporate-ir.net/phoenix.zhtml?c=187883&p=irol-reportsAnnual"]
]

